Cancer

  • To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.

  • African Americans less likely to be screened

    National guidelines for lung cancer screening are less effective for African Americans than for whites, Stanford study concludes. A risk-based analysis is more equitable and effective.

  • Lung cancer cells protected by brain cells

    Small cell lung cancers often metastasize to the brain. A Stanford Medicine study shows they thrive there by emulating developing neurons and recruiting surrounding cells for protection.

  • Reena Thomas gets $12 million CIRM grant

    The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.

  • Arc Institute awards

    Two professors are named Innovation Investigators, and four win Ignite Awards.

  • Big Ideas in Medicine

    Physicians, researchers and other pacesetters describe some of the most promising pursuits in the medical field. In cancer, for instance: ‘Let’s kill the first cell, not the last cell.’…

  • Real-time targeting of tumors

    New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.

  • AI could inform brain cancer prognosis

    Stanford Medicine scientists and colleagues create an algorithm that could help physicians better understand and target complicated brain tumors.

  • Tumor suppressor repairs tissue

    The tumor suppressor p53 has been in the limelight for decades. But its cancer-fighting function may be only a side effect of its role in tissue repair, a Stanford Medicine study finds.

  • Cancer center renovation

    The Laurie K. Lacob Pavilion at the Stanford Medicine Cancer Center opened July 17. The state-of-the-art facility, for transplant and cellular therapies, is a light-filled space for healing.

  • Predictable mutations chart cancer’s path

    Human cells evolving in the laboratory undergo a series of predictable, sequential genetic changes that lead to pre-cancer. Blocking these changes may allow intervention before cancer occurs.

  • VA, Stanford Medicine cancer collab

    An anticipated growth in veterans seeking cancer care catalyzes talks to develop state-of-the-art collaboration between VA and Stanford Medicine.


Related Websites